First-of-its-kind Pitt study allows some liver transplant recipients to stop antirejection drugs

First-of-its-kind Pitt study allows some liver transplant recipients to stop antirejection drugs

Original Source

Read the full article at Post-gazette →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.